These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15464660)

  • 1. Hepatitis C and steatosis.
    Dev A; Patel K; McHutchison JG
    Clin Liver Dis; 2004 Nov; 8(4):881-92, ix. PubMed ID: 15464660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steatosis and chronic hepatitis C virus infection: mechanisms and significance.
    Patel K; Zekry A; McHutchison JG
    Clin Liver Dis; 2005 Aug; 9(3):399-410, vi. PubMed ID: 16023973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.
    Liu CJ; Jeng YM; Chen PJ; Lai MY; Yang HC; Huang WL; Kao JH; Chen DS
    Antivir Ther; 2005; 10(3):405-15. PubMed ID: 15918331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic steatosis and hepatitis C: Still unhappy bedfellows?
    Hwang SJ; Lee SD
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():96-101. PubMed ID: 21199519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C.
    Castera L
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):125-34. PubMed ID: 16557184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C and steatosis: a reappraisal.
    Lonardo A; Loria P; Adinolfi LE; Carulli N; Ruggiero G
    J Viral Hepat; 2006 Feb; 13(2):73-80. PubMed ID: 16436124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steatosis and insulin resistance in response to treatment of chronic hepatitis C.
    Negro F
    J Viral Hepat; 2012 Jan; 19 Suppl 1():42-7. PubMed ID: 22233413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.
    Antúnez I; Aponte N; Fernández-Carbia A; Rodríguez-Perez F; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):57-60. PubMed ID: 16929588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
    Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
    Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.
    Hézode C; Zafrani ES; Roudot-Thoraval F; Costentin C; Hessami A; Bouvier-Alias M; Medkour F; Pawlostky JM; Lotersztajn S; Mallat A
    Gastroenterology; 2008 Feb; 134(2):432-9. PubMed ID: 18242211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C and steatosis.
    Monto A
    Semin Gastrointest Dis; 2002 Jan; 13(1):40-6. PubMed ID: 11944633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus-induced hepatocellular steatosis.
    Castera L; Chouteau P; Hezode C; Zafrani ES; Dhumeaux D; Pawlotsky JM
    Am J Gastroenterol; 2005 Mar; 100(3):711-5. PubMed ID: 15743372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: hepatitis C virus-associated steatosis--pathogenic mechanisms and clinical implications.
    Adinolfi LE; Durante-Mangoni E; Zampino R; Ruggiero G
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():52-5. PubMed ID: 16225474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C and steatosis.
    Björnsson E; Angulo P
    Arch Med Res; 2007 Aug; 38(6):621-7. PubMed ID: 17613353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steatosis in chronic hepatitis C: relationship to the virus and host risk factors.
    Matos CA; Perez RM; Pacheco MS; Figueiredo-Mendes CG; Lopes-Neto E; Oliveira EB; Lanzoni VP; Silva AE; Ferraz ML
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1236-9. PubMed ID: 16872303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections.
    Hézode C; Roudot-Thoraval F; Zafrani ES; Dhumeaux D; Pawlotsky JM
    J Viral Hepat; 2004 Sep; 11(5):455-8. PubMed ID: 15357652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus-induced steatosis: an overview.
    Negro F
    Dig Dis; 2010; 28(1):294-9. PubMed ID: 20460926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C infection and nonalcoholic fatty liver disease.
    Cheung O; Sanyal AJ
    Clin Liver Dis; 2008 Aug; 12(3):573-85, viii-ix. PubMed ID: 18625429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.